EW
Edwards Lifesciences Corp
86.30$
+0.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -46.2% | +28.1% | +42.1% | -7.4% | +27.3% | -10.6% | +64.3% | -29.7% | -26.5% | -39.5% | +194.2% | |
| – | -4.1% | +8.2% | +15.0% | -5.5% | +15.4% | +20.0% | +25.7% | +3.6% | +3.8% | +7.1% | +0.9% | |
| – | +3.3% | +14.0% | +8.3% | +15.3% | +14.5% | +13.9% | +18.0% | +16.0% | +9.9% | +16.4% | -2.6% | |
| – | – | – | – | +80.1% | +16.7% | -73.1% | -249.3% | – | – | – | – | |
| – | -66.2% | +2.6% | +254.3% | -118.2% | – | – | +244.3% | -390.0% | – | – | – | |
| – | +13.7% | +104.1% | -19.3% | +37.7% | +15.2% | +46.3% | -19.0% | -19.7% | +0.6% | -5.2% | +3.1% | |
| – | -50.1% | -33.0% | +205.7% | – | -876.8% | -10.9% | +224.3% | – | -31.1% | +1,230.8% | -130.8% | |
| – | -86.1% | +707.3% | -100.0% | – | -97.3% | +643.4% | +12.9% | -7.7% | +16.1% | – | – | |
| – | -6.9% | +136.5% | +15.2% | +4.2% | -66.9% | +137.5% | -18.0% | +236.8% | -49.1% | +31.8% | -22.9% | |
| – | – | +11,589.5% | -20.6% | -348.0% | -97.7% | -92.0% | +125.0% | -88.9% | +50.0% | – | – | |
| – | +3.7% | +69.3% | +76.2% | +132.7% | -89.5% | +321.2% | -26.8% | +344.7% | -55.1% | +38.3% | -2.7% | |
| – | -72.3% | +227.7% | -152.8% | – | – | -96.6% | -2,206.3% | – | – | +409.0% | -106.2% | |
| – | -52.3% | +9.9% | +69.4% | -17.0% | +31.5% | -28.2% | +116.7% | -32.0% | -34.0% | -53.9% | +360.5% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.